Supply Chain and Manufacturing

Latest Headlines

Latest Headlines

Groundbreaking held for the new $1.2B NABF animal health facility in Kansas

A groundbreaking ceremony was held Wednesday for the $1.2 billion National Bio and Agro-Defense Facility (NABF) currently under construction in Kansas.

AstraZeneca, betting on biologics, will build a $285M facility in Sweden

AstraZeneca CEO Pascal Soriot is counting on the company's cancer drug pipeline to help it climb out of the revenue hole it has fallen into, and he figures his company needs more manufacturing capacity for the coming launches.

Alexion adding a plant and a couple hundred jobs to its budding Irish base

Rare disease drugmaker Alexion has found a lot to love in Ireland. Taking advantage of that country's generous tax rate, it has turned that country into its European base of operations. With a pipeline of new drugs brewing, the rare disease specialist now intends to build a new plant and add a couple hundred more workers there.

Zoetis, under pressure from activist investor Ackman, will offload 10 plants to cut costs

Animal health leader Zoetis is using a move out of the Amgen playbook, whacking on manufacturing to cut costs and appease an aggressive activist investor.

WuXi starts up construction of China's largest biologics plant

WuXi Biologics is embarking on construction of what will be the biggest biologics plant in China once it's completed--an event the company expects by the end of next year.

Mylan recalls injectable cancer meds, most produced for Pfizer

Mylan is recalling 8 lots of injectable cancer drugs, most of them manufactured for Pfizer, after particulate was discovered in vials.

J&J pulls contraceptives in Canada on potency worries

J&J's Janssen unit is recalling one lot of Ortho-Cept contraceptive tablets because of the potential that the potency of the two active ingredients may not meet specifications, Health Canada reports.

Bayer closes MO animal health plant, citing excess capacity

After failing to sell its animal health production facility in St. Joseph, MO, Bayer HealthCare confirmed on Tuesday that it would close the site.

RB recalls 1.5M units of Mucinex on acetaminophen concerns

Getting too much of the pain reliever acetaminophen can be a serious issue, particularly for people with liver damage, and so U.K.-based Reckitt Benckiser thinks it best to recall 1.5 million bottles of Mucinex in the U.S. whose back labels don't match the front.

GSK yanks all doses of quadrivalent flu jab for potency problems

This past season's flu vaccines posted one of the worst efficacy rates in recent memory. That's partly because the viral strains they contained weren't the ones that ended up circulating. But on top of that, GlaxoSmithKline has uncovered some other effectiveness problems of its own--and now it's recalling a quadrivalent jab in a move that affects 1.7 million doses.